MWM
NUVB icon

Meridian Wealth Management’s Nuvation Bio NUVB Stock Holding History

Meridian Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$571K Buy
133,065
+19,500
+17% +$109K 0.02% 484
2025
Q4 		$1.02M Buy
113,565
+4,200
+4% +$26K 0.04% 348
2025
Q3 		$405K Buy
109,365
+22,250
+26% +$60.6K 0.02% 526
2025
Q2 		$170K Buy
87,115
+4,780
+6% +$9.96K 0.01% 649
2025
Q1 		$145K Sell
82,335
-2,505
-3% -$5.7K 0.01% 602
2024
Q4 		$226K Buy
84,840
+2,000
+2% +$5.15K 0.01% 581
2024
Q3 		$190K Buy
82,840
+26,495
+47% +$80.8K 0.01% 610
2024
Q2 		$165K Buy
+56,345
New +$172K 0.02% 278
2022
Q4 		– Sell
-11,850
Closed -$27K – 538
2022
Q3 		$27K Buy
11,850
+1,475
+14% +$4.21K ﹤0.01% 488
2022
Q2 		$34K Buy
+10,375
New +$45.2K ﹤0.01% 550

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Meridian Wealth Management's NUVB Position: Q1 2026 in Review

Meridian Wealth Management increased its Nuvation Bio (NUVB) stake by 17% in Q1 2026, buying an estimated $109K and bringing the position to 133,065 shares worth $571K. The position accounts for 0.02% of the portfolio, ranked #484.

Meridian Wealth Management first reported a position in NUVB in Q2 2022 and has held it in 10 quarters since. The position peaked at $1.02M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Meridian Wealth Management held 133,065 shares of Nuvation Bio worth $571K as of Q1 2026.
  • Meridian Wealth Management bought 19,500 Nuvation Bio shares in Q1 2026, an estimated $109K.
  • Nuvation Bio made up 0.02% of Meridian Wealth Management's portfolio in Q1 2026, its #484 holding.
  • Meridian Wealth Management first reported a position in Nuvation Bio in Q2 2022 and has held it in 10 quarters since.
  • Meridian Wealth Management's Nuvation Bio position peaked at $1.02M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.